BioCell Technology, LLC – Trademark Portfolio
Entity Type: 16
BioCell Technology, LLC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 10 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 13 trademarks are registered. Notable registered marks include I-SABI, LIQUID BIOCELL, BIOCELL COLLAGEN, COLLAGEN/HA MATRIX, and BIOCELL COLLAGEN II. The owner is based in Irvine, CA.
20 Truman Street, Suite 105
Irvine, CA 92620
Showing of trademarks Trademarks
Trademark Classifications
BioCell Technology, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does BioCell Technology, LLC have?
BioCell Technology, LLC has 13 U.S. trademarks filed with the USPTO. Of these, 13 registered.
What trademark classes does BioCell Technology, LLC file in?
BioCell Technology, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are BioCell Technology, LLC's most well-known trademarks?
BioCell Technology, LLC's registered trademark portfolio includes well-known marks such as I-SABI, LIQUID BIOCELL, BIOCELL COLLAGEN, COLLAGEN/HA MATRIX, and BIOCELL COLLAGEN II. These are among 13 currently registered trademarks in the portfolio.
What is BioCell Technology, LLC's trademark registration success rate?
BioCell Technology, LLC has a 100% trademark registration rate, with 13 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.